135 related articles for article (PubMed ID: 10669814)
21. Combined single nucleotide polymorphism-based genomic mapping and global gene expression profiling identifies novel chromosomal imbalances, mechanisms and candidate genes important in the pathogenesis of T-cell prolymphocytic leukemia with inv(14)(q11q32).
Dürig J; Bug S; Klein-Hitpass L; Boes T; Jöns T; Martin-Subero JI; Harder L; Baudis M; Dührsen U; Siebert R
Leukemia; 2007 Oct; 21(10):2153-63. PubMed ID: 17713554
[TBL] [Abstract][Full Text] [Related]
22. T-cell prolymphocytic leukemia: an aggressive T cell malignancy with frequent cutaneous tropism.
Magro CM; Morrison CD; Heerema N; Porcu P; Sroa N; Deng AC
J Am Acad Dermatol; 2006 Sep; 55(3):467-77. PubMed ID: 16908353
[TBL] [Abstract][Full Text] [Related]
23. [Cutaneous localization of T-cell prolymphocytic leukemia].
Thomas A; Dompmartin A; Troussard X; Moreau A; Manard C; Leroy D
Ann Dermatol Venereol; 1995; 122(8):526-9. PubMed ID: 8572493
[TBL] [Abstract][Full Text] [Related]
24. TCL1 is overexpressed in patients affected by adult T-cell leukemias.
Narducci MG; Stoppacciaro A; Imada K; Uchiyama T; Virgilio L; Lazzeri C; Croce CM; Russo G
Cancer Res; 1997 Dec; 57(24):5452-6. PubMed ID: 9407948
[TBL] [Abstract][Full Text] [Related]
25. Effect of rapamycin on mouse chronic lymphocytic leukemia and the development of nonhematopoietic malignancies in Emu-TCL1 transgenic mice.
Zanesi N; Aqeilan R; Drusco A; Kaou M; Sevignani C; Costinean S; Bortesi L; La Rocca G; Koldovsky P; Volinia S; Mancini R; Calin G; Scott CP; Pekarsky Y; Croce CM
Cancer Res; 2006 Jan; 66(2):915-20. PubMed ID: 16424025
[TBL] [Abstract][Full Text] [Related]
26. A gene on chromosome Xq28 associated with T-cell prolymphocytic leukemia in two patients with ataxia telangiectasia.
Thick J; Mak YF; Metcalfe J; Beatty D; Taylor AM
Leukemia; 1994 Apr; 8(4):564-73. PubMed ID: 8152252
[TBL] [Abstract][Full Text] [Related]
27. Application of cross-species color banding (RxFISH) in the study of T-prolymphocytic leukemia.
Espinet B; Solé F; Salido M; Lloveras E; Abella E; Besses C; Serrano S; Woessner S; Florensa L
Haematologica; 2000 Jun; 85(6):607-12. PubMed ID: 10870117
[TBL] [Abstract][Full Text] [Related]
28. In vitro and in vivo effectiveness of arsenic trioxide against murine T-cell prolymphocytic leukaemia.
Récher C; Chopin M; Raffoux E; Pierron G; Poupon J; Sigaux F; Dombret H; Stern MH
Br J Haematol; 2002 May; 117(2):343-50. PubMed ID: 11972516
[TBL] [Abstract][Full Text] [Related]
29. Evidence for Hox and E2A-PBX1 collaboration in mouse T-cell leukemia.
Bijl J; Krosl J; Lebert-Ghali CE; Vacher J; Mayotte N; Sauvageau G
Oncogene; 2008 Oct; 27(49):6356-64. PubMed ID: 18679416
[TBL] [Abstract][Full Text] [Related]
30. Structural basis for the co-activation of protein kinase B by T-cell leukemia-1 (TCL1) family proto-oncoproteins.
Auguin D; Barthe P; Royer C; Stern MH; Noguchi M; Arold ST; Roumestand C
J Biol Chem; 2004 Aug; 279(34):35890-902. PubMed ID: 15169787
[TBL] [Abstract][Full Text] [Related]
31. Inversions and tandem translocations involving chromosome 14q11 and 14q32 in T-prolymphocytic leukemia and T-cell leukemias in patients with ataxia telangiectasia.
Brito-Babapulle V; Catovsky D
Cancer Genet Cytogenet; 1991 Aug; 55(1):1-9. PubMed ID: 1913594
[TBL] [Abstract][Full Text] [Related]
32. Thymus-derived leukemia-lymphoma in mice transgenic for the Tax gene of human T-lymphotropic virus type I.
Hasegawa H; Sawa H; Lewis MJ; Orba Y; Sheehy N; Yamamoto Y; Ichinohe T; Tsunetsugu-Yokota Y; Katano H; Takahashi H; Matsuda J; Sata T; Kurata T; Nagashima K; Hall WW
Nat Med; 2006 Apr; 12(4):466-72. PubMed ID: 16550188
[TBL] [Abstract][Full Text] [Related]
33. Deregulated expression of TCL1 causes T cell leukemia in mice.
Virgilio L; Lazzeri C; Bichi R; Nibu K; Narducci MG; Russo G; Rothstein JL; Croce CM
Proc Natl Acad Sci U S A; 1998 Mar; 95(7):3885-9. PubMed ID: 9520462
[TBL] [Abstract][Full Text] [Related]
34. TCL1 is activated by chromosomal rearrangement or by hypomethylation.
Yuille MR; Condie A; Stone EM; Wilsher J; Bradshaw PS; Brooks L; Catovsky D
Genes Chromosomes Cancer; 2001 Apr; 30(4):336-41. PubMed ID: 11241786
[TBL] [Abstract][Full Text] [Related]
35. B-prolymphocytic leukaemia with t(11;14) revisited: a splenomegalic form of mantle cell lymphoma evolving with leukaemia.
Ruchlemer R; Parry-Jones N; Brito-Babapulle V; Attolico I; Wotherspoon AC; Matutes E; Catovsky D
Br J Haematol; 2004 May; 125(3):330-6. PubMed ID: 15086413
[TBL] [Abstract][Full Text] [Related]
36. Abnormalities at 14q32.1 in T cell malignancies involve two oncogenes.
Pekarsky Y; Hallas C; Isobe M; Russo G; Croce CM
Proc Natl Acad Sci U S A; 1999 Mar; 96(6):2949-51. PubMed ID: 10077617
[TBL] [Abstract][Full Text] [Related]
37. High incidence of proviral integrations in the Hoxa locus in a new model of E2a-PBX1-induced B-cell leukemia.
Bijl J; Sauvageau M; Thompson A; Sauvageau G
Genes Dev; 2005 Jan; 19(2):224-33. PubMed ID: 15655112
[TBL] [Abstract][Full Text] [Related]
38. Translocation (8;14)(q24;q32) as the sole cytogenetic abnormality in B-cell prolymphocytic leukemia.
Kuriakose P; Perveen N; Maeda K; Wiktor A; Van Dyke DL
Cancer Genet Cytogenet; 2004 Apr; 150(2):156-8. PubMed ID: 15066324
[TBL] [Abstract][Full Text] [Related]
39. The TCL1 family of oncoproteins: co-activators of transformation.
Teitell MA
Nat Rev Cancer; 2005 Aug; 5(8):640-8. PubMed ID: 16056259
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of the PRAD1 oncogene in a patient with prolymphocytic leukemia with t(11;14)(q13;q32).
Kobayashi H; Kitano K; Saito H; Aoki K; Narita A; Terada N; Sonoyama M; Uchimaru K; Machii T; Motokura T
Cancer Genet Cytogenet; 1995 Oct; 84(1):69-72. PubMed ID: 7497446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
